JP2024533122A5 - - Google Patents
Info
- Publication number
- JP2024533122A5 JP2024533122A5 JP2024513754A JP2024513754A JP2024533122A5 JP 2024533122 A5 JP2024533122 A5 JP 2024533122A5 JP 2024513754 A JP2024513754 A JP 2024513754A JP 2024513754 A JP2024513754 A JP 2024513754A JP 2024533122 A5 JP2024533122 A5 JP 2024533122A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- composition according
- alkyl
- virus
- aforementioned compound
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163240578P | 2021-09-03 | 2021-09-03 | |
| US63/240,578 | 2021-09-03 | ||
| PCT/US2022/042545 WO2023034617A1 (en) | 2021-09-03 | 2022-09-02 | 2'-chloro-2'-fluoro-n2-amino-n6-methylamino purine nucleotides for flavivirus treatment |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024533122A JP2024533122A (ja) | 2024-09-12 |
| JP2024533122A5 true JP2024533122A5 (https=) | 2025-09-09 |
Family
ID=85380756
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024513754A Pending JP2024533122A (ja) | 2021-09-03 | 2022-09-02 | フラビウイルス治療用の２’－クロロ－２’－フルオロ－ｎ２－アミノ－ｎ６－メチルアミノプリンヌクレオチド |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20240226131A1 (https=) |
| EP (1) | EP4395787A4 (https=) |
| JP (1) | JP2024533122A (https=) |
| KR (1) | KR20240052801A (https=) |
| CN (1) | CN118234499A (https=) |
| AU (1) | AU2022339679A1 (https=) |
| CA (1) | CA3174107A1 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL308921A (en) | 2021-06-17 | 2024-01-01 | Atea Pharmaceuticals Inc | Combination anti-HCV therapy is beneficial |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2018048937A1 (en) * | 2016-09-07 | 2018-03-15 | Atea Pharmaceuticals, Inc. | 2'-substituted-n6-substituted purine nucleotides for rna virus treatment |
| WO2021173713A1 (en) * | 2020-02-27 | 2021-09-02 | Atea Pharmaceuticals, Inc. | Highly active compounds against covid-19 |
-
2022
- 2022-09-02 JP JP2024513754A patent/JP2024533122A/ja active Pending
- 2022-09-02 CA CA3174107A patent/CA3174107A1/en active Pending
- 2022-09-02 AU AU2022339679A patent/AU2022339679A1/en active Pending
- 2022-09-02 EP EP22865638.5A patent/EP4395787A4/en active Pending
- 2022-09-02 CN CN202280073609.4A patent/CN118234499A/zh active Pending
- 2022-09-02 KR KR1020247010025A patent/KR20240052801A/ko active Pending
-
2024
- 2024-02-29 US US18/592,037 patent/US20240226131A1/en active Pending